Development and validation of a recurrence risk prediction model for elderly schizophrenia patients

老年精神分裂症患者复发风险预测模型的开发与验证

阅读:1

Abstract

OBJECTIVE: To construct a recurrence prediction model for Elderly Schizophrenia Patients (ESCZP) and validate the model's spatial external applicability. METHODS: The modeling cohort consisted of 365 ESCZP cases from the Seventh People's Hospital of Dalian, admitted between May 2022 and April 2024. Variables were selected using Lasso-Logistic regression to construct the recurrence prediction model, with a nomogram plotted using the "RMS" package in R 4.3.3 software. Model validation was performed using 1,000 bootstrap resamples. Spatial external validation was conducted using 172 cases ESCZP from the Fourth Affiliated Hospital of Qiqihar Medical College during the same period. The model's discrimination, accuracy, and clinical utility were assessed using Receiver Operating Characteristic (ROC) curves, Area Under the Curve (AUC), calibration curves, and Decision Curve Analysis (DCA). The Hosmer-Lemeshow test was used to evaluate model fit. RESULTS: A total of 537 cases ESCZP were included based on inclusion and exclusion criteria, with 150 recurrences within two years and 387 non-recurrences. Lasso-Logistic regression analysis identified Medication status, Premorbid personality, Exercise frequency, Drug adverse reactions, Family care, Social support, and Life events as predictors of ESCZP recurrence. The AUC for the modeling cohort was 0.877 (95% CI: 0.837-0.917). For the external validation cohort, the AUC was 0.838 (95% CI: 0.776-0.899). Calibration curves indicated that the fit was close to the reference line, demonstrating high model stability. DCA results showed good net benefit at a threshold probability of 80%. CONCLUSION: The nomogram prediction model developed based on Lasso-Logistic regression shows potential in identifying the risk of recurrence in ESCZP. However, further validation and refinement are needed before it can be applied in routine clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。